Breast Imaging Market
Report ID: SQMIG35D2340
Report ID: SQMIG35D2340
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35D2340 |
Region:
Global |
Published Date: August, 2025
Pages:
175
|Tables:
89
|Figures:
71
Global Breast Imaging Market size was valued at USD 5.18 Billion in 2024 and is poised to grow from USD 5.62 Billion in 2025 to USD 10.78 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026–2033).
The increasing global burden of breast cancer is a major driver of the breast imaging market. Factors such as aging populations, sedentary lifestyles, obesity, hormonal imbalances, and delayed childbearing are contributing to the rise in breast cancer cases worldwide. This growing incidence creates an urgent need for effective screening and diagnostic tools that can detect cancer at an early and more treatable stage. As a result, healthcare systems are investing heavily in advanced breast imaging technologies like 3D mammography (tomosynthesis), MRI, and automated ultrasound. These tools enhance early detection capabilities, directly impacting survival outcomes and driving sustained market growth.
Rapid advancements in imaging technologies are a key trend driving the global breast imaging sector. Innovations such as AI-powered diagnostic systems, digital breast tomosynthesis (DBT), contrast-enhanced spectral mammography (CESM), and portable ultrasound devices have significantly improved the accuracy, speed, and accessibility of breast cancer detection. These technologies help reduce false positives and unnecessary biopsies, improving diagnostic confidence among clinicians and patients alike. Additionally, the integration of machine learning algorithms enables better image interpretation and personalized risk assessments. As healthcare providers increasingly adopt these advanced tools, market demand grows, especially in regions focused on upgrading diagnostic infrastructure and implementing preventive healthcare strategies.
What Includes Cost-Benefit Considerations of Implementing AI-Based Breast Imaging Systems?
Artificial Intelligence (AI) is significantly impacting the global breast imaging market by enhancing diagnostic accuracy and efficiency. AI algorithms can analyze mammograms, ultrasounds, and MRIs to detect subtle patterns often missed by human eyes, leading to earlier and more accurate breast cancer detection. This reduces false positives and unnecessary biopsies, improving patient outcomes and clinician confidence. As a result, healthcare facilities are integrating AI-powered solutions into imaging workflows. A notable development is Google Health’s AI system, which demonstrated accuracy comparable to radiologists in detecting breast cancer from mammograms. Such advancements are accelerating AI adoption, driving innovation and expanding the breast imaging market.
In November 2024, iCAD received FDA clearance for ProFound Detection Version 4.0, an AI-powered breast imaging platform for digital breast tomosynthesis. This update significantly improved early cancer detection in dense breast tissue and reduced false positives, driving greater clinical adoption and advancing AI integration in global breast imaging workflows.
Market snapshot - 2026-2033
Global Market Size
USD 4.4 Billion
Largest Segment
Ionizing
Fastest Growth
Non Ionizing
Growth Rate
8.5% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global breast imaging market is segmented based on technology, end use, product, and region. In terms of technology, the market is bifurcated into ionizing and non-ionizing. Based on end use, the market is trifurcated into hospitals, breast care centers, and diagnostic imaging centers. Based on product, the market is grouped into breast imaging systems, software & service, and accessories. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.
Based on the global breast imaging market forecast, ionizing technology, particularly digital mammography and 3D tomosynthesis, continues to dominate the industry due to its proven effectiveness in early cancer detection. Innovations such as photon-counting mammography have enhanced image resolution while reducing radiation exposure. These technologies are widely adopted due to established clinical guidelines, high diagnostic accuracy, and strong reimbursement support. Their reliability and scalability make ionizing methods the preferred choice for routine breast cancer screening worldwide.
Non-ionizing technologies are the fastest-growing segment in the global breast imaging market due to their safety, especially for frequent screening and use in younger or high-risk populations. Modalities like breast MRI and ultrasound offer excellent performance in dense tissue without radiation exposure, driving adoption amid rising awareness and improved reimbursement policies.
Hospitals remain the dominant end users in the global breast imaging market due to their ability to offer comprehensive diagnostic services under one roof. They handle high patient volumes and are equipped with advanced imaging systems, skilled radiologists, and integrated care pathways. Innovations such as AI-assisted diagnostics and digital tomosynthesis are widely implemented in hospitals. Their infrastructure, funding capabilities, and trust among patients solidify their leading position in this market segment.
Diagnostic imaging centers are the fastest-growing end-use segment in the global breast imaging market due to their cost-effectiveness, faster service delivery, and increasing presence in urban and semi-urban areas. As demand for routine breast cancer screening rises, these centers attract patients seeking convenience, specialized care, and quicker access to advanced imaging technologies.
To get detailed segments analysis, Request a Free Sample Report
As per the global breast imaging market analysis, North America leads the industry, driven by high breast cancer incidence, advanced healthcare infrastructure, and strong adoption of innovative imaging technologies. The U.S. dominates due to favorable reimbursement policies, widespread screening programs, and continuous R&D investments. Rising awareness, government initiatives like the CDC’s Breast Cancer Program, and early integration of AI-driven diagnostics further strengthen the region’s leadership in delivering accurate, accessible, and timely breast cancer detection services.
The United States dominates North America’s breast imaging market due to its advanced healthcare infrastructure, high breast cancer prevalence, and widespread adoption of technologies like 3D mammography and AI-assisted diagnostics. Government-backed screening programs, strong reimbursement frameworks, and ongoing R&D investments further drive growth. With a well-established clinical ecosystem and increasing awareness, the U.S. continues to be the largest contributor to regional and global advancements in breast imaging technologies.
Canada contributes significantly to North America’s breast imaging market through robust public health initiatives and growing investments in diagnostic infrastructure. The country emphasizes early detection via national screening programs and is expanding access to advanced imaging technologies in both urban and rural areas. Rising breast cancer incidence, improved reimbursement policies, and increasing use of non-ionizing modalities like ultrasound and MRI support Canada’s continued growth and innovation in the breast imaging sector.
Asia Pacific is emerging as the fastest-growing region in the global breast imaging market, fueled by rising breast cancer cases, improving healthcare access, and growing awareness about early detection. Countries like China, Japan, and India are investing heavily in modern imaging infrastructure. Government-led screening initiatives, increased healthcare spending, and rapid urbanization are driving demand. Additionally, local innovation and international collaborations are expanding access to both ionizing and non-ionizing imaging technologies.
Japan is a key contributor to the Asia Pacific breast imaging market due to its advanced healthcare system and strong emphasis on early cancer detection. The government actively promotes regular breast screening through national health programs. High adoption of digital mammography, tomosynthesis, and AI-based diagnostic tools enhances accuracy and efficiency. Japan’s focus on technological innovation, aging population, and widespread public awareness make it a vital player in advancing breast imaging across the Asia-Pacific region.
South Korea contributes significantly to the Asia Pacific breast imaging market through rapid adoption of advanced diagnostic technologies and strong public health infrastructure. The country emphasizes early breast cancer detection via nationwide screening initiatives and has integrated AI-driven imaging systems in many hospitals. High healthcare investment, public awareness campaigns, and a tech-savvy medical ecosystem support South Korea’s growing role as a regional leader in breast imaging innovation and accessibility.
Europe holds a significant share in the global breast imaging market, driven by rising breast cancer awareness, strong government-funded screening programs, and advanced healthcare infrastructure. Countries like Germany, the UK, and France lead in adopting cutting-edge technologies, including AI-powered diagnostics and digital breast tomosynthesis. Supportive regulatory frameworks, aging populations, and increasing healthcare investments further fuel demand, positioning Europe as a key region for innovation and growth in breast imaging solutions.
Germany plays a leading role in the Europe breast imaging market due to its advanced healthcare infrastructure and well-established national screening programs. The country has rapidly adopted digital mammography, 3D tomosynthesis, and AI-assisted diagnostics across hospitals and diagnostic centers. Strong government support, favorable reimbursement policies, and a high level of public awareness contribute to early detection initiatives, making Germany a key driver of innovation and revenue in the global breast imaging landscape.
France significantly contributes to the Europe breast imaging market through its organized national screening programs and state-funded healthcare initiatives. The government’s “Plan Cancer” emphasizes early detection, promoting widespread use of digital breast imaging technologies. Public and private healthcare providers increasingly adopt 3D mammography and breast MRI, supported by favorable reimbursement. With rising cancer awareness and technological modernization, France continues to expand its influence in the European and global breast imaging markets.
The United Kingdom supports the Europe breast imaging market with its NHS Breast Screening Programme, which offers routine screening to millions of women. Investment in digital breast imaging and artificial intelligence technologies has increased diagnostic accuracy and efficiency. The UK’s strong regulatory framework, public awareness campaigns, and commitment to early cancer detection drive steady growth, positioning the country as a major player in advancing breast imaging innovation and accessibility.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Government Screening Programs
Increasing Healthcare Expenditure
Radiation Exposure Concerns
Limited Reimbursement Policies
Request Free Customization of this report to help us to meet your business objectives.
The global breast imaging market outlook is highly competitive, with major players focusing on innovation, partnerships, and geographic expansion. Key international companies include Hologic Inc., GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Fujifilm Holdings. Hologic leads with AI-integrated tomosynthesis systems, while GE HealthCare focuses on expanding access in emerging markets. Siemens emphasizes precision diagnostics through AI-driven imaging platforms. These strategic moves strengthen market presence and drive technological advancement in breast cancer detection.
As per the global breast imaging industry analysis, the startup landscape is rapidly evolving, driven by demand for safer, faster, and more accessible diagnostics. Startups are leveraging AI, thermal imaging, and portable solutions to improve early detection and reduce reliance on costly infrastructure. Many focus on underserved regions and dense breast tissue challenges. Their innovations, often validated through clinical trials and regulatory approvals, are reshaping screening paradigms, enhancing diagnostic accuracy, and expanding global access to breast cancer detection.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global breast imaging industry is undergoing a transformative phase, fueled by rising breast cancer prevalence, advancements in diagnostic technologies, and increasing government support for early detection initiatives. AI integration, innovation in both ionizing and non-ionizing modalities, and growing preference for personalized screening are reshaping the landscape. While hospitals dominate with advanced infrastructure, diagnostic imaging centers and startups are expanding access and affordability.
North America remains the largest contributor, while Asia-Pacific is witnessing the fastest growth. Leading global players and emerging startups continue to innovate with AI-driven solutions and portable imaging systems, improving accuracy and reducing disparities in access. As demand for early, accurate, and patient-centered breast cancer diagnostics grows, the global breast imaging market revenue is set to experience sustained and inclusive global expansion.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 5.18 Billion |
| Market size value in 2033 | USD 10.78 Billion |
| Growth Rate | 8.5% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Breast Imaging Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Breast Imaging Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Breast Imaging Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Breast Imaging Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
